# Progress Note 02 — Focused Visit (Intermediate follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Gregory Boyington (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET008-SYN-TD
- Date: 1957-08-11
- Fictional facility: St. Posthumous Health Center
- Fictional author: Elena Marquez, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Intermediate follow-up)

## Chief complaint

Six-week alcohol use disorder and PTSD follow-up. **S**

## History of present illness

Mr. Boyington returns six weeks after his intake visit, where he chose behavioral treatment for alcohol use disorder and was referred for trauma-focused psychotherapy. He began prolonged exposure therapy with Dr. Lee in behavioral health in early July and has attended five weekly sessions; Dr. Lee's consultation report came this morning. He has also gone to his veteran recovery peer group most weeks. Before treatment he drank most days, usually seven to nine drinks. In the six weeks since intake he drank on about four days, usually five beers. After a run of nightmares in the third week of therapy, when the imaginal exposure work began, he had one day of more than six drinks. He did not drive and called a peer from his group the next morning. He has had no tremor, sweats, or withdrawal symptoms. He sleeps about five and a half hours, with nightmares about twice a week instead of most nights, and he startles less at loud noises. He has had no thoughts of suicide or self-harm since intake and still keeps the written safety plan in his wallet. He has lost 1.3 kg and attributes it to fewer drinks. **S**

| Element | Detail |
|---|---|
| Drinking since intake | About four drinking days in six weeks, usually five beers; one day of more than six drinks after a run of nightmares; AUDIT-C 5, down from 10 |
| Trauma symptoms | Nightmares about twice a week, down from most nights; less startle; PCL-5 31, down from 39 |
| Mood | Somewhat better; PHQ-9 6, down from 9, with item 9 scored 0 |
| Treatment engagement | Five prolonged exposure sessions with Dr. Lee; recovery peer group most weeks |
| Safety | No suicidal thoughts, intent, or plan since intake; safety plan kept and reviewed |
| Medicines | None, including no over-the-counter sleep aids |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight down 1.3 kg, which he attributes to drinking less; no fever or night sweats |
| Gastrointestinal | Negative | No abdominal pain, vomiting, black stool, or jaundice |
| Neurological | Negative | No tremor, seizures, or numbness in the feet |
| Psychiatric | Positive | Nightmares about twice a week, intrusive memories after therapy sessions, less startle; no suicidal thoughts; no cravings most days |
| Sleep | Positive | About five and a half hours a night with early waking |

5 systems reviewed. **S**

## Current medications

- No current medications. **S**

## Allergies

- No known allergy **S**

## Objective

BP 130/84 mmHg; pulse 76 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 87.1 kg; BMI 27.5 kg/m². All vital signs are synthetic.

Total score [AUDIT-C]: 5; PTSD PCL-5 score [PCL-5]: 31; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]: 6. All results are synthetic.

## Change since baseline

- Total score [AUDIT-C]: 10 at baseline, 5 at this visit **S**
- PTSD PCL-5 score [PCL-5]: 39 at baseline, 31 at this visit **S**
- Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]: 9 at baseline, 6 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Alert, well groomed, no smell of alcohol; no tremor or sweating |
| Eyes | Sclerae anicteric |
| Abdomen | Soft and non-tender; liver edge not palpable; no spider angiomas or palmar erythema |
| Mental status | Calm and engaged; mood “better, still on edge”; affect mildly anxious and congruent; thought process linear; no suicidal or homicidal ideation; insight and judgment good |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Alcohol use disorder, early recovery with one heavy-drinking day** (F10.20). AUDIT-C has fallen from 10 to 5 and drinking days from most days to about four in six weeks. The one heavy-drinking day followed a run of nightmares early in exposure therapy, a common and expected strain point, and he used his relapse plan the next day. Blood pressure has fallen to 130/84 mmHg and weight by 1.3 kg. No withdrawal signs and no sign of liver disease on examination. **S**
   - Continue behavioral treatment and the veteran recovery peer group.
   - Naltrexone and acamprosate offered again; he prefers to continue without medication for now and will reconsider if heavy drinking recurs.
   - Relapse plan updated: on nights after a hard therapy session, call a peer and keep no alcohol in the house.
   - Hepatic panel and GGT to be drawn with the preventive-visit blood tests in the fall, as he prefers a single blood draw.
2. **Post-traumatic stress disorder, improving in trauma-focused psychotherapy** (F43.10). PCL-5 has fallen from 39 to 31, an 8-point fall, short of the 10 points usually taken as a meaningful change, but nightmares and startle are improving. Dr. Lee confirms the diagnosis and recommends finishing the prolonged exposure course. **S**
   - Continue weekly prolonged exposure with Dr. Lee.
   - No benzodiazepines or sedative sleep medicines.
   - Repeat PCL-5, AUDIT-C, and PHQ-9 at twelve weeks.
3. **Suicide risk and safety plan**. No suicidal ideation, intent, or plan since intake, and PHQ-9 item 9 is 0. Protective factors are unchanged: engagement in treatment, veteran and recovery peers, and a strong sense of service. Low acute risk. **S**
   - Safety plan reviewed and still current; lethal-means safety unchanged since intake.
   - Crisis line number confirmed in his phone: 988, press 1 for the Veterans Crisis Line.
4. **Sleep disturbance with nightmares**. Improving with trauma treatment and less drinking; still about five and a half hours a night. **S**
   - Regular rise time, no alcohol as a sleep aid, and wind-down routine after therapy evenings.
   - If insomnia persists after the therapy course, offer cognitive behavioral therapy for insomnia.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | AUDIT-C | Baseline, then at six and twelve weeks by the care plan, and at every visit in early recovery | Completed today | 5, down from 10; one heavy-drinking day since intake |
| Survey | PCL-5 | Baseline and during trauma-focused psychotherapy; care plan at six and twelve weeks | Completed today | 31, down 8 points from 39 |
| Survey | PHQ-9 | Baseline, then periodically while symptoms are followed | Completed today | 6, down from 9; item 9 scored 0. No depressive disorder is diagnosed |
| Survey | Suicide-risk reassessment and safety plan review | Every visit | Completed today | No ideation, intent, or plan since the intake safety assessment; safety plan reviewed and current; lethal-means safety unchanged |
| Referral | Trauma-focused psychotherapy (prolonged exposure) | Weekly course, usually 8 to 15 sessions | Up to date | Five sessions with Dr. Lee since early July; consultation report received today |
| Self-management | Recovery peer group and relapse plan | Weekly group; plan reviewed every visit | Completed today | Attends most weeks; relapse plan updated for nights after therapy sessions |
| Medication safety | Offer of medication for alcohol use disorder | At diagnosis and whenever drinking goals are not met | Completed today | Naltrexone and acamprosate re-offered after the heavy-drinking day; he prefers to continue behavioral treatment |
| Laboratory | Hepatic panel and GGT | Baseline with heavy drinking, and before starting naltrexone | Deferred | Not drawn at intake despite near-daily heavy drinking, a gap in the baseline workup. No medication depends on it and there is no sign of liver disease today, so no harm is expected. Planned with his preventive-visit blood tests in the fall, his preference |
| Medication safety | Avoid benzodiazepines and sedative-hypnotics | Every visit | Completed today | None prescribed; no over-the-counter sleep aids |
| Examination | Blood pressure, weight, and signs of intoxication, withdrawal, or liver disease | Every visit | Completed today | 130/84 mmHg, down from 134/86; weight 87.1 kg, down 1.3 kg; no withdrawal signs or liver stigmata |
| Self-management | Sleep and nightmares | Every visit | Completed today | About five and a half hours a night; nightmares about twice a week, down from most nights |

## Goal progress

- Reduce AUDIT-C score from 10 to 3 or lower by twelve weeks. In progress; target 1957-09-30. **S**
- Reduce PCL-5 score from 39 to 25 or lower by twelve weeks. In progress; target 1957-09-30. **S**
- Attend at least eight integrated therapy or recovery-support sessions by twelve weeks. In progress; target 1957-09-30. **S**

## Guideline basis

- VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023), United States Department of Veterans Affairs and Department of Defense
- Recommend Evidence-Based Treatment: Know the Options (2026 accessed), National Institute on Alcohol Abuse and Alcoholism
- CMID: Clinical Monitoring Intelligence Database, depression monograph (2026), Aether Forge

## Follow-up

- Weekly prolonged exposure with Dr. Lee and the recovery peer group. Three-month care-plan review with AUDIT-C, PCL-5, and PHQ-9. Call or use the crisis line at any time for thoughts of suicide or a return to heavy drinking. **S**
- Next scheduled visit 1957-09-30: three-month recovery care-plan review. **S**
